✦ LIBER ✦

Isolated limb perfusion for melanoma patients—a review of its indications and the role of tumour necrosis factor-α

✍ Scribed by D.J. Grünhagen; J.H.W. de Wilt; A.N. van Geel; A.M.M. Eggermont

Book ID: 116442621
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 168 KB
Volume: 32
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2006.01.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of isolated limb perfu

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

✍ J. P. Deroose; D. J. Grünhagen; A. N. van Geel; J. H. W. de Wilt; A. M. M. Egger 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

The palliative value of tumor necrosis f

The palliative value of tumor necrosis factor α-based isolated limb perfusion in patients with metastatic sarcoma and melanoma

✍ Dirk J. Grunhagen; Johannes H. W. de Wilt; Wilfried J. Graveland; Albertus N. va 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Isolated limb perfusion with tumour necr

Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity

✍ J. Bickels; E.R. Manusama; M. Gutman; A.M.M. Eggermont; Y. Kollender; S. Abu-Abi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Efficacy of Repeat Isolated Limb Perfusi

Efficacy of Repeat Isolated Limb Perfusions With Tumor Necrosis Factor α and Melphalan for Multiple In-Transit Metastases in Patients with Prior Isolated Limb Perfusion Failure

✍ Dirk J. Grünhagen; Boudewijn van Etten; Flavia Brunstein; Wilfried J. Graveland; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 106 KB

Isolated limb perfusion with tumor necro

Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

✍ Eva M. Noorda; Bart C. Vrouenraets; Omgo E. Nieweg; Frits van Coevorden; Gooike 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using

Synergistic antitumour effect of recombi

Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat

✍ Dr E. R. Manusama; P. T. G. A. Nooijen; J. Stavast; N. M. C. Durante; R. L. Marq 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB